Concepts (89)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Orbital Neoplasms | 1 | 2019 | 11 | 0.610 |
Why?
|
| Vision Disorders | 1 | 2019 | 38 | 0.600 |
Why?
|
| Hepatitis C | 1 | 2019 | 40 | 0.600 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2019 | 131 | 0.550 |
Why?
|
| Liver Neoplasms | 1 | 2019 | 166 | 0.530 |
Why?
|
| Peritoneal Diseases | 1 | 2013 | 1 | 0.430 |
Why?
|
| Gravidity | 1 | 2013 | 6 | 0.430 |
Why?
|
| Fetal Membranes, Premature Rupture | 1 | 2013 | 6 | 0.430 |
Why?
|
| Decidua | 1 | 2013 | 4 | 0.430 |
Why?
|
| Thyroid Gland | 1 | 2013 | 32 | 0.420 |
Why?
|
| Cesarean Section | 1 | 2013 | 55 | 0.410 |
Why?
|
| Thyroid Neoplasms | 1 | 2013 | 39 | 0.410 |
Why?
|
| Carcinoma | 1 | 2013 | 75 | 0.400 |
Why?
|
| Peritoneal Neoplasms | 1 | 2013 | 79 | 0.400 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2013 | 330 | 0.350 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2025 | 76 | 0.270 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2019 | 24 | 0.260 |
Why?
|
| Biomarkers, Tumor | 3 | 2013 | 406 | 0.230 |
Why?
|
| Lighting | 1 | 2024 | 9 | 0.220 |
Why?
|
| Microscopy | 1 | 2024 | 38 | 0.220 |
Why?
|
| Protein Kinases | 1 | 2025 | 158 | 0.220 |
Why?
|
| Image Processing, Computer-Assisted | 1 | 2024 | 257 | 0.190 |
Why?
|
| Leiomyosarcoma | 1 | 2022 | 10 | 0.190 |
Why?
|
| Papillomavirus Infections | 1 | 2022 | 144 | 0.170 |
Why?
|
| Ovarian Neoplasms | 1 | 2025 | 595 | 0.150 |
Why?
|
| Middle Aged | 4 | 2022 | 7164 | 0.150 |
Why?
|
| Visual Acuity | 1 | 2019 | 111 | 0.140 |
Why?
|
| Palliative Care | 1 | 2019 | 82 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 463 | 0.140 |
Why?
|
| Humans | 8 | 2025 | 28168 | 0.130 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2019 | 477 | 0.120 |
Why?
|
| Pregnancy, Twin | 1 | 2013 | 6 | 0.110 |
Why?
|
| Carcinoma, Medullary | 1 | 2013 | 1 | 0.110 |
Why?
|
| Female | 5 | 2025 | 15192 | 0.110 |
Why?
|
| Thyroidectomy | 1 | 2013 | 6 | 0.110 |
Why?
|
| Carcinoma, Neuroendocrine | 1 | 2013 | 14 | 0.100 |
Why?
|
| Carcinoid Tumor | 1 | 2013 | 3 | 0.100 |
Why?
|
| Drug Therapy | 1 | 2013 | 15 | 0.100 |
Why?
|
| Biopsy | 1 | 2013 | 207 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 372 | 0.100 |
Why?
|
| Ultrasonography | 1 | 2013 | 241 | 0.100 |
Why?
|
| Predictive Value of Tests | 1 | 2013 | 475 | 0.100 |
Why?
|
| Male | 3 | 2019 | 13511 | 0.090 |
Why?
|
| Neuroendocrine Tumors | 1 | 2010 | 29 | 0.080 |
Why?
|
| Cell Line, Tumor | 3 | 2025 | 1327 | 0.080 |
Why?
|
| Pregnancy | 1 | 2013 | 1191 | 0.080 |
Why?
|
| Retrospective Studies | 2 | 2013 | 2558 | 0.080 |
Why?
|
| Risk Factors | 1 | 2013 | 2087 | 0.070 |
Why?
|
| Pancreatic Neoplasms | 1 | 2013 | 534 | 0.070 |
Why?
|
| HSP70 Heat-Shock Proteins | 1 | 2025 | 49 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2010 | 678 | 0.060 |
Why?
|
| Color | 1 | 2024 | 23 | 0.060 |
Why?
|
| Fourier Analysis | 1 | 2024 | 31 | 0.060 |
Why?
|
| Adult | 2 | 2013 | 7765 | 0.050 |
Why?
|
| Retinoblastoma Binding Proteins | 1 | 2022 | 2 | 0.050 |
Why?
|
| Mitochondria | 1 | 2025 | 366 | 0.050 |
Why?
|
| In Situ Hybridization | 1 | 2022 | 34 | 0.050 |
Why?
|
| Triazines | 2 | 2013 | 11 | 0.050 |
Why?
|
| Benzoquinones | 2 | 2013 | 26 | 0.050 |
Why?
|
| Lactams, Macrocyclic | 2 | 2013 | 26 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 2 | 2013 | 75 | 0.050 |
Why?
|
| Papillomaviridae | 1 | 2022 | 88 | 0.050 |
Why?
|
| Pyrazoles | 2 | 2013 | 66 | 0.040 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2022 | 103 | 0.040 |
Why?
|
| Mice | 1 | 2025 | 4655 | 0.030 |
Why?
|
| Receptors, Somatostatin | 1 | 2013 | 8 | 0.030 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2013 | 10 | 0.030 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 9 | 0.030 |
Why?
|
| Receptors, Transforming Growth Factor beta | 1 | 2013 | 9 | 0.030 |
Why?
|
| Receptor, ErbB-2 | 1 | 2013 | 33 | 0.030 |
Why?
|
| ras Proteins | 1 | 2013 | 43 | 0.030 |
Why?
|
| Indazoles | 1 | 2013 | 18 | 0.030 |
Why?
|
| Imidazoles | 1 | 2013 | 63 | 0.030 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2013 | 41 | 0.030 |
Why?
|
| Receptor, Platelet-Derived Growth Factor alpha | 1 | 2013 | 31 | 0.020 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2013 | 65 | 0.020 |
Why?
|
| ErbB Receptors | 1 | 2013 | 101 | 0.020 |
Why?
|
| HSP90 Heat-Shock Proteins | 1 | 2013 | 61 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2013 | 140 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2013 | 157 | 0.020 |
Why?
|
| Cell Survival | 1 | 2013 | 408 | 0.020 |
Why?
|
| Animals | 1 | 2025 | 10416 | 0.020 |
Why?
|
| Tissue Array Analysis | 1 | 2010 | 24 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2010 | 269 | 0.020 |
Why?
|
| Mutation | 1 | 2013 | 849 | 0.020 |
Why?
|
| Blotting, Western | 1 | 2010 | 513 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2010 | 2021 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 2738 | 0.010 |
Why?
|
| Aged | 1 | 2010 | 5417 | 0.010 |
Why?
|